EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial

Myrthe M G Moermans, Shima Ahmady, Patty J Nelemans, Aimée H M M Arits, Janneke P H M Kessels, Han P A van Pelt, Nicole W J Kelleners-Smeets, Klara Mosterd

Journal of the American Academy of Dermatology · 2026

DOI: 10.1016/j.jaad.2025.12.034 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Myrthe M G Moermans und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Maastricht University Medical Center+, Maastricht, The Netherlands; GROW Research Institute for Oncology and Reproduction,…. Hauptthemen laut MEDLINE: Bowen's Disease, Fluorouracil, Photochemotherapy, Skin Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evidence on long-term efficacy with head-to-head comparison of different treatments for Bowen's disease (BD) is lacking. OBJECTIVE: To compare the long-term efficacy of 5-fluorouracil and methylaminolevulinate photodynamic therapy (MAL-PDT) versus surgical excision (SE) in BD. METHODS: In this multicenter, non-inferiority randomized controlled trial, 250 patients with BD were invited for long-term follow-up, 3 to 5 years post-treatment. Patients had been randomly assigned to 5FU, MAL-PDT, or SE in a 1:1:1-ratio. The primary outcome was the cumulative probability of tumor-free survival 4 years post-treatment with treatment failures confirmed histopathologically. A secondary endpoint was the risk of cutaneous squamous cell carcinoma (cSCC). RESULTS: During the first year of follow-up, treatment failure was observed in 27 patients. During long-term follow-up, only 1 additional patient developed a recurrence, 5 years after MAL-PDT. The 4-year cumulative probability of tumor-free survival was 97.5% for SE (95% confidence interval (CI) 90.4-99.4), 86.2% for 5FU (95% CI 76.4-92.1), and 82.7% for MAL-PDT (95% CI 72.6-89.4). No patient developed a cSCC in the treated area. LIMITATIONS: Loss to follow-up occurred in 23.2% of patients. CONCLUSIONS: During long-term follow-up, the additional risk of recurrence of BD after 5FU and SE, and the risk of developing a cSCC from a treated BD were negligible. Treatment with 5FU remains non-inferior to SE, whereas non-inferiority of MAL-PDT could not be concluded.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bowen's DiseaseFluorouracilPhotochemotherapySkin NeoplasmsAminolevulinic AcidDermatologic Surgical ProceduresHumansFemaleMaleAgedMiddle AgedFollow-Up StudiesPhotosensitizing AgentsAged, 80 and overNeoplasm Recurrence, LocalCarcinoma, Squamous CellAdministration, CutaneousTreatment OutcomeTime FactorsAdministration, Topical

Stichwörter der Autor:innen

Bowen's diseaseclinical researchdrug responsefluorouraciloncologyphotodynamic therapyskin cancersquamous cell carcinomasurgerytherapy

Substanzen

FluorouracilAminolevulinic Acidmethyl 5-aminolevulinatePhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Dermatology, Maastricht University Medical Center+, Maastricht, The Netherlands; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. Electronic addres…
  • Department of Dermatology, Maastricht University Medical Center+, Maastricht, The Netherlands; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.
  • Department of Dermatology, Catharina Hospital, Eindhoven, The Netherlands.
  • Department of Dermatology, Zuyderland Medical Center, Heerlen, The Netherlands.
  • Department of Dermatology, VieCuri Medical Center, Venlo, The Netherlands.

Zitieren

APA

Moermans, M. M. G., Ahmady, S., Nelemans, P. J., Arits, A. H. M. M., Kessels, J. P. H. M., van Pelt, H. P. A., Kelleners-Smeets, N. W. J., & Mosterd, K. (2026). Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.12.034

Vancouver

Moermans MMG, Ahmady S, Nelemans PJ, Arits AHMM, Kessels JPHM, van Pelt HPA, et al. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2025.12.034

BibTeX
@article{Moermans2026,
  author = {Moermans, Myrthe M G and Ahmady, Shima and Nelemans, Patty J and Arits, Aimée H M M and Kessels, Janneke P H M and van Pelt, Han P A and Kelleners-Smeets, Nicole W J and Mosterd, Klara},
  title = {Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen's disease: Long-term results of a multicenter randomized controlled trial},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2025.12.034}
}
Kostenlos starten →